Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
7
|
pubmed:dateCreated |
1991-4-4
|
pubmed:abstractText |
Differences of affinity to and selectivity for trimebutine between peripheral and central opioid receptors have been investigated. Trimebutine inhibited electrically induced contraction of guinea-pig ileum (GPI) and mouse vas deferens (MVD) but not of rabbit vas deferens, and the inhibition was antagonized by naloxone and, to lesser extent, by nor-binaltorphimine (nor-BNI). The pA2 values for morphine and trimebutine with naloxone were higher than the values for these compounds with nor-BNI in both GPI and MVD preparations. GPI preparations incubated with a high concentration of morphine or trimebutine developed tolerance; however, there was no cross-tolerance between them, suggesting difference in the underlying mechanisms. In mouse and guinea-pig brain homogenate trimebutine was about 1/13 as potent as morphine to displace the [3H]naloxone binding, while it has no appreciable affinity for kappa-opioid receptors in [3H]U-69593, a selective kappa-receptor agonist. These results suggest that trimebutine, showing its low affinity to opioid receptors, possesses mu-receptor selective properties rather than those of kappa-opioid receptor in the peripheral tissues and in the central brain homogenate.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Morphine,
http://linkedlifedata.com/resource/pubmed/chemical/Naloxone,
http://linkedlifedata.com/resource/pubmed/chemical/Naltrexone,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Opioid,
http://linkedlifedata.com/resource/pubmed/chemical/Trimebutine,
http://linkedlifedata.com/resource/pubmed/chemical/norbinaltorphimine
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0386-846X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
13
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
448-53
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:1963196-Animals,
pubmed-meshheading:1963196-Drug Tolerance,
pubmed-meshheading:1963196-Guinea Pigs,
pubmed-meshheading:1963196-Ileum,
pubmed-meshheading:1963196-Male,
pubmed-meshheading:1963196-Mice,
pubmed-meshheading:1963196-Morphine,
pubmed-meshheading:1963196-Muscle, Smooth,
pubmed-meshheading:1963196-Muscle Contraction,
pubmed-meshheading:1963196-Naloxone,
pubmed-meshheading:1963196-Naltrexone,
pubmed-meshheading:1963196-Rabbits,
pubmed-meshheading:1963196-Receptors, Opioid,
pubmed-meshheading:1963196-Trimebutine,
pubmed-meshheading:1963196-Vas Deferens
|
pubmed:year |
1990
|
pubmed:articleTitle |
The opioid receptor selectivity for trimebutine in isolated tissues experiments and receptor binding studies.
|
pubmed:affiliation |
Department of Pharmacology, Faculty of Pharmaceutical Sciences, Nagasaki University, Japan.
|
pubmed:publicationType |
Journal Article,
Comparative Study
|